^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Germ Cell Tumors
    Regimen:TI-CE (carboplatin + etoposide IV + ifosfamide + paclitaxel)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Second-line Chemotherapy Regimens for Metastatic Germ Cell tumors…High-Dose Chemotherapy Regimens…Preferred Regimens…Paclitaxel/Ifosamide/Carboplatin/Etoposide
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Third-line Chemotherapy Regimens for Metastatic Germ Cell tumors…High-Dose Chemotherapy NOT previously Received…Preferred Regimens (High-dose Chemotherapy)…Paclitaxel/Ifosamide/Carboplatin/Etoposide…